Myriad Genetics buy Raymond James
Start price
03.03.23
/
50%
€21.85
Target price
03.03.24
€25.45
Performance (%)
-7.55%
End price
04.03.24
€20.20
Summary
This prediction ended on 04.03.24 with a price of €20.20. With a performance of -7.55%, the BUY prediction for Myriad Genetics by Raymond_James closed slightly in the red. Raymond_James has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Myriad Genetics | 10.891% | 10.891% | -54.286% | -79.478% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % | 52,75 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % | 88,39 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % | 59,41 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % | 60,39 % |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Raymond James from $25.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten